A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether fish oil (containing omega-3 fatty acids)
given enterally is safe and effective in reducing lung and systemic inflammation seen in
acute lung injury.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborators:
Acute Respiratory Distress Syndrome Foundation American Society for Parenteral and Enteral Nutrition American Thoracic Society National Heart, Lung, and Blood Institute (NHLBI)